Publications

2024

  • NAWROT, D.; AMBROŻKIEWICZ-MOSLER, W.; DOLEŽAL, M.; BOUZ, G. Antistaphylococcal discovery pipeline; where are we now? Eur. J. Med. Chem., 2024, vol. 266, 116077 [ISSN 0223-5234], IF2022 = 7.088 (Q1), doi: 10.1016/j.ejmech.2023.116077

2023

  • KERDA, M.; ŠLECHTA, P.; JAND'OUREK, O.; KONEČNÁ, K.; HATOKOVÁ, P.; PATEROVÁ, P.; ZITKO, J. N-Pyrazinylhydroxybenzamides as biologically active compounds: a hit-expansion study and antimicrobial evaluation. Future Med. Chem., 2023 (epub ahead of print). [ISSN 1756-8927], IF2022 = 4.2 (Q2), doi: 10.4155/fmc-2023-0189

  • NAWROT, D. E.; BOUZ, G.; JANĎOUREK, O.; KONEČNÁ, K.; PATEROVÁ, P.; BÁRTA, P.; NOVÁK, M.; KUČERA, R.; ZEMANOVÁ, J.; FORBAK, M.; KORDULÁKOVÁ, J.; PAVLIŠ, O.; KUBÍČKOVÁ, P.; DOLEŽAL, M.; ZITKO, J. Antimycobacterial pyridine carboxamides: From design to in vivo activity. Eur. J. Med. Chem., 2023, vol. 258, 115617.  [ISSN 0223-5234], IF2022 = 6.700 (Q1), doi: 10.1016/j.ejmech.2023.115617

  • ŠLECHTA, P., NEEDLE, A. A., JANĎOUREK, O., PATEROVÁ, P., KONEČNÁ, K., BÁRTA, P., KUNEŠ., J., KUBÍČEK, V., DOLEŽAL, M., and KUČEROVÁ-CHLUPÁČOVÁ, M.: Design, Synthesis, and Antimicrobial Evaluation of New N-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)(hetero)aryl-2-carboxamides as Potential Inhibitors of Mycobacterial Leucyl-tRNA Synthetase, Int. J. Mol. Sci. 2023, vol. 24, no. 3, article no. 2951.  [ISSN 1422-0067],  IF2021 = 6.208; Q1 in Biochemistry and Molecular Biology (69/296)/Q2 in Chemistry, multidisciplinary (50/179); AIS2021 = 1.064; Q2 in Biochemistry and Molecular Biology (102/296)/Q2 in Chemistry, multidisciplinary (49/178), doi: 10.3390/ijms24032951

  • STEPANIĆ, V., AND KUČEROVÁ-CHLUPÁČOVÁ, M.: Review and Chemoinformatic Analysis of Ferroptosis Modulators with a Focus on Natural Plant Products, Molecules, 2023, vol. 28, article no. 475. [ISSN 1420-3049], IF2021 = 4.927; AIS2021 = 0.671, doi: 10.3390/molecules28020475 
  • BOUZ, G.; ŠLECHTA, P.; JAND’OUREK, O.; KONEČNÁ, K.; PATEROVÁ, P.; BÁRTA, P.; NOVÁK, M.; KUČERA, R.; DAL, N.-J. K.; FENAROLI, F.; ZEMANOVÁ, J.; FORBAK, M.; KORDULÁKOVÁ, J.; PAVLIŠ, O.; KUBÍČKOVÁ, P.; DOLEŽAL, M.; ZITKO, J. Hybridization Approach Toward Novel Antituberculars: Design, Synthesis, and Biological Evaluation of Compounds Combining Pyrazinamide and 4-Aminosalicylic Acid. ACS Infect. Dis., 2023, vol. 9, no. 1, p. 79-96. [ISSN 2373-8227], IF2021 =5.578 (D1), doi: 10.1021/acsinfecdis.2c00433  Free Access Link (Valid for 50 downloads, for 1 year)

2022

  • PALLABOTHULA, V.S.K.; KERDA, M.; JUHÁS, M.; JANĎOUREK, O.; KONEČNÁ, K.; BÁRTA, P.; PATEROVÁ, P.; ZITKO, J. Adenosine-Mimicking Derivatives of 3-Aminopyrazine-2-Carboxamide: Towards Inhibitors of Prolyl-tRNA Synthetase with Antimycobacterial Activity. Biomolecules, 2022, vol. 12, article no. 1561. [ISSN 2218-273X], IF2021 = 6.064, doi: 10.3390/biom12111561
  • KONEČNÁ, K.; DIEPOLTOVÁ, A.; HOLMANOVÁ, P.; JAND’OUREK, O.; VEJSOVÁ, M.; VOXOVÁ, B.; BÁRTA, P.; MAIXNEROVÁ, J.; TREJTNAR, F.; KUČEROVÁ-CHLUPÁČOVÁ. M. Comprehensive insight into anti-staphylococcal and anti-enterococcal action of brominated and chlorinated pyrazine-based chalcones. Front. Microbiol., 2022, vol. 13, article no. 912467. [ISSN 1664-302X], IF2021 = 6.064 (Q1) https://doi.org/10.3389/fmicb.2022.912467 
  • JUHÁS, M.; BACHTÍKOVÁ, A.; NAWROT, D.E.; HATOKOVÁ, P.; PALLABOTHULA, V.S.K.; DIEPOLTOVÁ, A.; JANĎOUREK, O.; BÁRTA, P.; KONEČNÁ, K.; PATEROVÁ, P.; ŠESTÁK, V.; ZITKO, J. Improving Antimicrobial Activity and Physico-Chemical Properties by Isosteric Replacement of 2-Aminothiazole with 2-Aminooxazole. Pharmaceuticals, 2022, vol. 15, article no. 580. [ISSN 1424-8247], IF2020 = 5.863 (Q1Q1), doi:  10.3390/ph15050580
  • ZALEM, D.; JUHÁS, M.; TERRINONI, M.; KING-LYONS, N.; LEBENS, M.; VARROT, A.; CONNELL, T. D.; TENEBERG, S. Characterization of the ganglioside recognition profile of Escherichia coli heat-labile enterotoxin LT-IIc. Glycobiology, 2021. Accepted manuscript. ISSN [0959-6658], IF2020 = 4.313, doi: 10.1093/glycob/cwab133 
  • JUHÁS, M.; PALLABOTHULA, V. S. K.; GRABRIJAN, K.; ŠIMOVIČOVÁ, M.; JANĎOUREK, O.; KONEČNÁ, K.; BÁRTA, P.; PATEROVÁ, P.; GOBEC, S.; SOSIČ, I.; ZITKO, J. Design, synthesis and biological evaluation of substituted 3-amino-N-(thiazol-2-yl)pyrazine-2-carboxamides as inhibitors of mycobacterial methionine aminopeptidase 1. Bioorg. Chem., 2022, vol. 118, article no. 105489.  [ISSN 0045-2068], IF2020 = 5.275, doi: 10.1016/j.bioorg.2021.105489     Free Access link until Jan 20, 2022

2021

  • BOUZ, G.; DOLEŽAL, M. Advances in Antifungal Drug Development: An Up-To-Date Mini Review. Pharmaceuticals, 2021, vol. 14, article no.1312. [ISSN 1424-8247], IF2020 = 5.863 (Q1Q1), doi: 10.3390/ph14121312
  • BOUZ, G.; BOUZ, S.; JANĎOUREK, O.; KONEČNÁ, K.; BÁRTA, P.; VINŠOVÁ, J.; DOLEŽAL, M.; ZITKO, J. Synthesis, Biological Evaluation, and In Silico Modeling of N-Substituted Quinoxaline-2-Carboxamides. Pharmaceuticals, 2021, vol. 14, article no. 768. [ISSN 1424-8247], IF2020 = 5.863 (Q1Q1), doi: 10.3390/ph14080768
  • PANG, L.; WEEKS, S.D.; JUHÁS, M.; STRELKOV, S.V.; ZITKO, J.; VAN AERSCHOT, A. Towards Novel 3-Aminopyrazinamide-Based Prolyl-tRNA Synthetase Inhibitors: In Silico Modelling, Thermal Shift Assay and Structural Studies. Int. J. Mol. Sci., 2021, vol. 22, article no. 7793. [ISSN 1422-0067], IF2020 = 5.923 (Q1Q2), doi: 10.3390/ijms22157793
  • TENHUNEN, J.; KUČERA, T.; HUOVINEN, M.; KÜBLBECK, J.; BISENIEKS, E.; VIGANTE, B.; OGLE, Z.; DUBURS, G.; DOLEŽAL, M.; MOADDEL, R.; LAHTELA-KAKKONEN, M.; RAHNASTO-RILLA, M. Screening of SIRT6 modulators and activators: A novel activator has an impact on breast cancer cells. Biomed. Pharmacother., 2021, vol. 138, art. no. 111452. [ISSN 0753-3322], IF2020 = 6.529, JCR category rank: 15/186 (D1) in Medicine, Research & Experimental, 20/352 (Q1) in Pharmacology & Pharmacy, doi: 10.1016/j.biopha.2021.111452  
  • BOUZ, G.; ZITKO J. Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: An up-to-date review. Bioorg. Chem., 2021, vol. 110, article no. 104806. [ISSN 0045-2068], IF2020 = 5.275, doi: 10.1016/j.bioorg.2021.104806
  • NAWROT, D.; SUCHÁNKOVÁ, E.; JANĎOUREK, O.; KONEČNÁ, K.; BÁRTA, P.; DOLEŽAL, M.; ZITKO, J. N‐pyridinylbenzamides: an isosteric approach towards new antimycobacterial compounds. Chem. Biol. Drug. Des., 2021, vol. 97, p. 686–700. [ISSN 1747-0277], IF2020 = 2.817, doi: 10.1111/cbdd.13804

2020

  • KUCEROVA-CHLUPACOVA, M., HALAKOVA, D., MAJEKOVA, M., TREML, J., STEFEK, M., SOLTESOVA PRNOVA, M.: (4-Oxo-2-thioxothiazolidin-3-yl)acetic acids as potent and selective aldose reductase inhibitors. Chem.-Biol. Interact. 2020, vol. 332, 109286. [ISSN 0009-2797], IF2020 = 5.192 (Q1Q2) doi: 10.1016/j.cbi.2020.109286 
  • KAPKOWSKI, M.; LUDYNIA, M.; RUDNICKA, M.; DZIDA, M.; ZORĘBSKI, E.; MUSIAŁ, M.; DOLEŽAL, M.; POLANSKI, J. Enhancing the CO2 capturing ability in leaf via xenobiotic auxin uptake. Science of the Total Environment, 2020, vol. 745, article no. 141032. [ISSN 0048-9697], IF2020 = 7.963, (Q1) in ‚Environmental Chemistry‘, doi: 10.1016/j.scitotenv.2020.141032
  • JUHÁS, M.; ZITKO, J. Molecular Interactions of Pyrazine-based Compounds to Proteins. J. Med. Chem. 2020, vol. 63, no. 17, p. 8901–8916. [ISSN 0022-2623], IF2020 = 7.446 (D1), doi: 10.1021/acs.jmedchem.9b02021
  • AMBROŻKIEWICZ, W.; KUČEROVÁ-CHLUPÁČOVÁ, M.; JANĎOUREK, O.; KONEČNÁ, K.; PATEROVÁ, P.; BÁRTA, P.; VINŠOVÁ, J.; DOLEŽAL, M.; ZITKO, J. 5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation. Molecules, 2020, vol. 25, article no. 1561. [ISSN 1420-3049], IF2020 = 4.411 (Q2Q2), doi: 10.3390/molecules25071561
  • JUHÁS, M.; KUČEROVÁ, L.; HORÁČEK, O.; JANĎOUREK, O.; KUBÍČEK, V.; KONEČNÁ, K.; KUČERA, R.; BÁRTA, P.; JANOUŠEK, J.; PATEROVÁ, P.; KUNEŠ, J.; DOLEŽAL, M.; ZITKO, J. N-Pyrazinoyl Substituted Amino Acids as Potential Antimycobacterial Agents—The Synthesis and Biological Evaluation of Enantiomers. Molecules, 2020, vol. 25, article no. 1518. [ISSN 1420-3049], IF2020 = 4.411 (Q2Q2), doi: 10.3390/molecules25071518
  • BOUZ, G.; JUHÁS, M.; PAUSAS OTERO, L.; PAREDES DE LA RED, C.; JANĎOUREK, O.; KONEČNÁ, K.; PATEROVÁ, P.; KUBÍČEK, V.; JANOUŠEK, J.; DOLEŽAL, M.; ZITKO, J. Substituted N-(pyrazin-2-yl)benzenesulfonamides; Synthesis, Anti-infective Evaluation, Cytotoxicity, and In silico Studies. Molecules, 2020, vol. 25, no. 1, article no. 138. [ISSN 1420-3049], IF2020 = 4.411 (Q2Q2), doi: 10.3390/molecules25010138
  • BEEGUM, S.; MARY, Y. S.; MARY, Y. S.; THOMAS, R.; ARMAKOVIĆ, S.; ARMAKOVIĆ, S. J.; ZITKO, J.; DOLEŽAL, M.; VAN ALSENOY, C. Exploring the detailed spectroscopic characteristics, chemical and biological activity of two cyanopyrazine-2-derivatives using experimental and theoretical tools. Spectrochim. Acta Part A: Mol. Biomol. Spectr., 2020, vol. 224, art. no. 117414. [ISSN 1386-1425], IF2020 = 4.098, doi: 10.1016/j.saa.2019.117414

2019

  • KAPKOWSKI, M.; LUDYNIA, M.; POLAŃSKI, J.; RUDNICKA, M.; DZIDA, M.; BALIN, K.; DOLEŽAL, M.; KASTNER, P. Kompozycja poprawiająca penetrację substancji biologicznie aktywnych przez powierzchnie organów roślinnych. Zgloszenie patentowe, P.430248; 02-07-2019 PDF
  • KAPKOWSKI, M.; LUDYNIA, M.; POLAŃSKI, J.; RUDNICKA, M.; DZIDA, M.; BALIN, K.; DOLEŽAL, M.; KASTNER, P. Směs usnadňující penetraci biologicky aktivních látek povrchem do rostlinných orgánů. Přihláška českého patentu PV 2019-614; 02-10-2019 PDF
  • STEPANIĆ, V., MATIJAŠIĆ, M., HORVAT, T., VERBENAC, D., KUČEROVÁ-CHLUPÁČOVÁ, M., SASO, L., ŽARKOVIĆ, N.: Antioxidant Activities of Alkyl Substituted Pyrazine Derivatives of Chalcones— In Vitro and In Silico Study. Antioxidants,  2019, vol. 8, no. 4, article no. 90.  [ISSN 2076-3921], IF2019 = 5.014 (Q1Q1Q1) doi:10.3390/antiox8040090;
  • BOUZ, G.; SEMELKOVÁ, L.; JANĎOUREK, O.; KONEČNÁ, K.; PATEROVÁ, P.; NAVRÁTILOVÁ, L.; KUBÍČEK, V.; KUNEŠ, J.; DOLEŽAL, M.; ZITKO, J. Derivatives of 3-Aminopyrazine-2-carboxamides: Synthesis, Antimicrobial Evaluation, and in Vitro Cytotoxicity. Molecules, 2019, vol. 24, no. 7, article no. 1212. [ISSN 1420-3049], IF2019 = 3.267, doi: 10.3390/molecules24071212

2018

  • BOUZ, G. The zebrafish model of tuberculosis - no lungs needed. Critical Reviews in Microbiology, 2018, vol. 44, no.6, pp 779-792.   [ISSN 1040-841X], IF2018: 5.697 (Q1),  doi: 10.1080/1040841X.2018.1523132
  • ZITKO, J.; MINDLOVÁ, A.; VALÁŠEK, O.; JANĎOUREK, O.; PATEROVÁ, P.; JANOUŠEK, J.; KONEČNÁ, K.; DOLEŽAL, M. Design, Synthesis and Evaluation of N-pyrazinylbenzamides as Potential Antimycobacterial Agents. Molecules, 2018, vol. 23, no. 9, article no. 2390. [ISSN 1420-3049], IF2017 = 3.098, doi: 10.3390/molecules23092390
  • ZITKO, J.; JANĎOUREK, O.; PATEROVÁ, P.; NAVRÁTILOVÁ, L.; KUNEŠ, J.; VINŠOVÁ, J.; DOLEŽAL, M. Design, synthesis and antimycobacterial activity of hybrid molecules combining pyrazinamide with 4-phenylthiazol-2-amine scaffold. MedChemComm, 2018, vol. 9, p. 685–696. [ISSN 2040-2503], IF2016: 2.608, doi: 10.1039/C8MD00056E
  • ZITKO, J.; DOLEŽAL, M. Old Drugs and New Targets as an Outlook for the Treatment of Tuberculosis. Curr. Med. Chem., 2018, vol. 25, No. 38, p. 5142–5167. [ISSN 1875-533X], IF2017: 3.469, doi: 10.2174/0929867324666170920154325
  • KUCEROVA-CHLUPACOVA, M.; DOSEDEL, M.; KUNES, J.; SOLTESOVA-PRNOVA, M.; MAJEKOVA, M.; STEFEK, M.: Chalcones and their pyrazine analogs: synthesis, inhibition of aldose reductase, antioxidant activity, and molecular docking study. Mon. Chem. 2018, vol. 149, No. 5, p. 921–929.  [ISSN 0026-9247],  IF2018 = 1.501 (Q3), doi: 10.1007/s00706-018-2146-6

2017

  • MUCAJI, P.; ATANASOV, A. G.; BAK, A.; KOZIK, V.; SIERON, K.; OLSEN, M.; PAN, W.; LIU, Y.; HU, S.; LAN, J.; HAIDER, N.; MUSIOL, R.; VANCO, J.; DIEDERICH, M.; JI, S.; ZITKO, J. The Forty-Sixth Euro Congress on Drug Synthesis and Analysis: Snapshot †. Molecules, 2017, vol. 22, no. 11, article no. 1848. [ISSN 1420-3049], IF2016 = 2.861, doi:10.3390/molecules22111848
  • BOUZ, G.; JUHÁS, M.; NIKLOVÁ, P.; JANĎOUREK, O.; PATEROVÁ, P.; JANOUŠEK, J.; TŮMOVÁ, L.; KOVALÍKOVÁ, Z.; KASTNER, P.; DOLEŽAL, M.; ZITKO, J. Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors. Molecules, 2017, vol. 22, no. 10, article no. 1797. [ISSN 1420-3049], IF2016 = 2.861, doi: 10.3390/molecules22101797
  • SEMELKOVÁ, L.; JANOŠCOVÁ, P.; FERNANDES, C.; BOUZ, G.; JANĎOUREK, O.; KONEČNÁ, K.; PATEROVÁ, P.; NAVRÁTILOVÁ, L.; KUNEŠ, J.; DOLEŽAL, M.; ZITKO, J. Design, Synthesis, Antimycobacterial Evaluation, and In Silico Studies of 3-(Phenylcarbamoyl)-pyrazine-2-carboxylic Acids. Molecules, 2017, vol. 22, no. 9, Article No. 1491.  [ISSN 1420-3049], IF2016 = 2.861, doi: 10.3390/molecules22091491
  • JOSEPH, T.; VARGHESE, H. T.; PANICKER, C. Y.; VISWANATHAN, K.; DOLEŽAL, M.; ALSENOY, C. V. Spectroscopic (FT-IR, FT-Raman), first order hyperpolarizability, NBO analysis, HOMO and LUMO analysis of N-[(4-(trifluoromethyl)phenyl]pyrazine-2-carboxamide by density functional methods. Arab. J. Chem., 2017, vol. 10, no. S2, p. S2281–S2294. [ISSN 1878-5352], IF2016 = 4.553, doi: 10.1016/j.arabjc.2013.08.004
  • SEMELKOVÁ, L.; JANĎOUREK, O.; KONEČNÁ, K.; PATEROVÁ, P.; NAVRÁTILOVÁ, L.; TREJTNAR, F.; KUBÍČEK, V.; KUNEŠ, J.; DOLEŽAL, M.; ZITKO, J. 3-Substituted N-Benzylpyrazine-2-carboxamide Derivatives: Synthesis, Antimycobacterial and Antibacterial Evaluation. Molecules, 2017, vol. 22, no. 3, Article No. 495. [ISSN 1420-3049] IF2015 = 2.465, doi:10.3390/molecules22030495
  • JANDOUREK, O.; TAUCHMAN, M.; PATEROVA, P.; KONECNA, K.; NAVRATILOVA, L.; KUBICEK, V.; HOLAS, O.; ZITKO, J.; DOLEZAL, M. Synthesis of Novel Pyrazinamide Derivatives Based on 3-Chloropyrazine-2-carboxamide and Their Antimicrobial Evaluation. Molecules, 2017, vol. 22, no. 2, Article No. 223. [ISSN 1420-3049] IF2015 = 2.465, doi: 10.3390/molecules22020223
  • P.K. RANJITH, ; EBTEHAL S. AL-ABDULLAH, FATMAH A.M. AL-OMARY, ALI A. EL-EMAM, P.L. ANTO, MARY Y. SHEENA, STEVAN ARMAKOVIĆ, SANJA J. ARMAKOVIĆ, JAN ZITKO, MARTIN DOLEZAL, C. VAN ALSENOY. FT-IR and FT-Raman characterization and investigation of reactive properties of N-(3-iodo-4-methylphenyl)pyrazine-2-carboxamide by molecular dynamics simulations and DFT calculations. J. Mol. Struct., 2017, vol. 1136, p. 14–24. [ISSN 0022-2860] IF2015 = 1.780, doi: 10.1016/j.molstruc.2017.01.079
  • BEEGUM, S.; MARY, Y. S.; VARGHESE, H. T.; PANICKER, C. Y.; ARMAKOVIĆ, S.; ARMAKOVIĆ, S. J.; ZITKO, J.; DOLEŽAL, M.; VAN ALSENOY, C. Vibrational spectroscopic analysis of cyanopyrazine-2-carboxamide derivatives and investigation of their reactive properties by DFT calculations and molecular dynamics simulations. J. Mol. Struct., 2017, vol. 1131, p. 1–15. [ISSN 0022-2860] IF2015 = 1.780, doi: 10.1016/j.molstruc.2016.11.044

2016

  • Sebastian, S. H. R.; Al-Alshaikh, M. A.; El-Emam, A. A.; SHEENA MARY, Y.; Panicker, C. Y.; JOJO, P. J.; Zitko, J.; Doležal, m. Synthesis, spectroscopic investigations, quantum chemical studies, molecular docking  and antiviral activity of 5-chloro-N-(2-chlorophenyl)pyrazine-2-carboxamide. Sci. Adv. Today, 2016, vol. 2, art. no. 25239. [ISSN 2455-2321], https://fac.ksu.edu.sa/sites/default/files/synthesis_spectroscopic_investigations_quantum.pdf
  • ZITKO, J.; DOLEŽAL, M. Enoyl acyl carrier protein reductase inhibitors: an updated patent review (2011 – 2015). Exp. Opin. Ther. Pat., 2016, vol. 26, p. 1079-1094.  [ISSN 1354-3776 (Print)], [ISSN 1744-7674 (Online)]. IF2015: 4.626. doi: 10.1080/13543776.2016.1211112.
  • OPLETALOVA, V.; DOLEZEL, J.; KUNES, J.; BUCHTA, V.; VEJSOVA, M.; KUCEROVA-CHLUPACOVA, M.: Synthesis and Antifungal Screening of 2-{[1-(5-Alkyl/arylalkylpyrazin-2-yl)ethylidene]hydrazono}-1,3-thiazolidin-4-ones. Molecules 2016, vol. 21, no. 11, p. 1592. [ISSN 1420-3049] IF2016 = 2.861 (Q2Q2) doi:10.3390/molecules21111592
  • KUCEROVA-CHLUPACOVA, M.; VYSKOVSKA-TYLLOVA, V.; RICHTEROVA-FINKOVA, L.; KUNES, J.; BUCHTA, V.; VEJSOVA, M.; PATEROVA, P.; SEMELKOVA, L.; JANDOUREK, O.; OPLETALOVA, V.: Novel Halogenated Pyrazine-Based Chalcones as Potential Antimicrobial Drugs. Molecules 2016, vol. 21, no. 11, p. 1421. [ISSN 1420-3049], IF2016 = 2.861(Q2Q2) doi: 10.3390/molecules21111421
  • DOLEŽAL, M.; ZITKO, J.; JANĎOUREK, O.; SERVUSOVÁ-VAŇÁSKOVÁ B. Substituted 2-(2-phenylhydrazinyl)pyrazine, process for its preparation, its use and a pharmaceutical composition containing the same. WO 2016/095877 A1 (PCT/CZ2015/000127).
  • DOLEŽAL, M.; ZITKO, J.; JANĎOUREK, O.; SERVUSOVÁ-VAŇÁSKOVÁ B. Substituovaný 2-(2-fenylhydrazinyl)pyrazin, způsob jeho přípravy, jeho použití a farmaceutický přípravek ho obsahující. PV 2014-925.
  • SEBASTIAN, S. H. R.; AL-ALSHAIKH, M. A.; EL-EMAM, A. A.; PANICKER, C. Y.; ZITKO, J.; DOLEZAL, M.; VAN ALSENOY, C. Spectroscopic, quantum chemical studies, Fukui functions, in vitro antiviral activity and molecular docking of 5-chloro-N-(3-nitrophenyl)pyrazine-2-carboxamide. J. Mol. Struct.,  2016, vol. 1119, p. 188–199. [ISSN 0022-2860] IF2015 = 1.780, doi: 10.1016/j.molstruc.2016.04.088
  • HROCH, L.; BENEK, O.; GUEST, P.; AITKEN, L.; SOUKUP, O.; JANOČKOVÁ, J.; MUSIL, K.; DOHNAL, V.; DOLEŽAL, R.; KUČA, K.; SMITH, T. K.; GUNN-MOORE, F.; MUSÍLEK, K. Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer’s disease treatment. Bioorg. Med. Chem. Lett., 2016, vol. 26, p. 3675–3678. [ISSN 0960-894X]. IF2015 = 2.486, doi: 10.1016/j.bmcl.2016.05.087
  • TŮMOVÁ, L.; TŮMA, J.; DOLEŽAL, M.; DUČAIOVÁ, Z.; KUBEŠ J. New Synthetic Pyrazinecarboxamide Derivatives as Potential Elicitors in Production of Secondary Metabolite in In vitro Cultures. Pharmacogn. Mag., 2016, vol. 12, no. 45, Suppl. 1, p. 57–62. [ISSN 0976-4062], IF2014 = 1.256, doi: 10.4103/0973-1296.176117

  • ZITKO, J.; SERVUSOVA-VANASKOVA, B.; PATEROVA, P.; NAVRATILOVA, L.; TREJTNAR, F.; KUNES, J.; DOLEZAL, M. Design, Synthesis and Antimycobacterial Evaluation of Some New N-Phenylpyrazine-2-Carboxamides. Chem. Pap., 2016, vol. 70, no. 5, p. 649–657. [ISSN (Online) 1336-9075], [ISSN (Print) 0366-6352], IF2014 = 1.468. doi: 10.1515/chempap-2015-0246

2015

  • ZITKO, J.; DOLEŽAL, M. Indole-carboxamide derivatives: a patent evaluation of WO2015036412A1. Exp. Opin. Ther. Pat., 2015, vol. 25, p. 1487–1494. [ISSN 1354-3776]. IF2014 = 4.297. doi: 10.1517/13543776.2015.1101066
  • HIRSOVA, P.; DOLEZEL, J.; KUCEROVA-CHLUPACOVA, M.; KUNES, J.; PILAROVA, V.; NOVAKOVA, L.; OPLETALOVA, V. (Z)-3-Amino-5-(pyridin-2-ylmethylidene)-2-thioxo-1,3-thiazolidin-4-one. Molbank, 2015, vol. 2015, M872. [ISSN 1422-8599]. doi: 10.3390/M872
  • MAREK, J.; MALIŇÁK, D.; DOLEŽAL, R.; SOUKUP, O.; PASDIOROVÁ, M.; DOLEŽAL, M.; KUČA, K. Synthesis and disinfection effect of the pyridine-4-aldoxime based salts. Molecules, 2015, vol. 20, no. 3, p. 3681-3696. [ISSN 1420-3049], IF2014 = 2.095; doi: 10.3390/molecules20033681
  • RESMI, K. S.; PANICKER, C. Y.; ZITKO, J.; DOLEZAL, M.; WAR, J.A.; SRIVASTAVA, S. K.; VAN ALSENOY, C. FT-IR, FT-Raman, NBO, HOMO-LUMO analysis and molecular docking study of 5-chloro-N-(2-fluorophenyl)pyrazine-2-carboxamide. Sci. Lett., 2015, vol. 4, p. 216. [ISSN 2454–7239].
  • SERVUSOVA-VANASKOVA, B.; JANDOUREK, O.; PATEROVA, P.; KORDULAKOVA, J.; PLEVAKOVA, M.; KUBICEK, V.; KUCERA, R.; GARAJ, V.; NAESENS, L.; KUNES, J.; DOLEZAL, M.; ZITKO, J. Alkylamino derivatives of N-benzylpyrazine-2-carboxamide: Synthesis and antimycobacterial evaluation. MedChemComm, 2015, vol. 6, p. 13111317. [ISSN 2040-2503], IF2013 = 2.626. doi: 10.1039/C5MD00178A
  • SEMELKOVA, L.; KONECNA, K.; PATEROVA, P.; KUBICEK, V.; KUNES, J.; NOVAKOVA, L.; MAREK, J.; NAESENS, L.; PESKO, M.; KRALOVA, K.; DOLEZAL, M.; ZITKO, J. Synthesis and Biological Evaluation of N-Alkyl-3-(alkylamino)-pyrazine-2-carboxamides. Molecules, 2015, vol. 20, p. 8687–8711. [ISSN 1420-3049], IF2013 = 2.095. doi: 10.3390/molecules20058687
  • ZITKO, J.; FRANCO, F.; PATEROVÁ, P. Synthesis and anti-infective evaluation of 5-amino-N-phenylpyrazine-2-carboxamides. Čes. Slov. Farm., 2015, vol. 64, p. 19–24. [ISSN 1210-7816].
  • JANĎOUREK, O.; KUNEŠ, J.; DOLEŽAL, M.; Microwave-Assisted Synthesis of Pyrazinamide Derivatives: the Coupling Reaction of 3-Chloropyrazine-2-Carboxamide and Ring-Substituted Anilines. Curr. Org. Synthesis, 2015, vol. 12, no. 2, p. 189–196. [ISSN 1875-6271], IF2014 = 2.117. doi: 10.2174/1570179411999141106101501
  • HOLAS, O.; SLOVÁK, F.; DOLEŽAL, M. Computational approach to search for novel antituberculotics. Čes. Slov. Farm., 2015, vol. 64, no. 1-2, p. 32–33. [ISSN 1803-6597].
  • SERVUSOVÁ-VAŇÁSKOVÁ, B.; PATEROVÁ P.; GARAJ, V.; MANDÍKOVA, J.; KUNEŠ J.; NAESENS, L.; JÍLEK, P.; DOLEŽAL, M.; ZITKO, J. Synthesis and antimicrobial evaluation of 6-alkylamino-N-phenyl-pyrazine-2-carboxamides. Chem. Biol. Drug Des., 2015, vol. 86, p. 674–681. [ISSN 1747-0285].  IF2013 = 2.507. doi: 10.1111/cbdd.12536
  • KUCEROVA-CHLUPACOVA, M.; KUNES, J.; BUCHTA, V.; VEJSOVA, M.; OPLETALOVA, V. Novel Pyrazine Analogs of Chalcones: Synthesis and Evaluation of Their Antifungal and Antimycobacterial Activity. Molecules, 2015, vol. 20, p. 1104–1117. [ISSN 1420-3049], IF2015 = 2.465 (Q2Q2) doi: 10.3390/molecules20011104.
  • HROCH, L.; AITKEN, L.; BENEK, O.; DOLEŽAL, M.; KUČA, K.; GUNN-MOORE, F.; MUSÍLEK, K. Benzothiazoles - Scaffold of Interest for CNS Targeted Drugs. Curr. Med. Chem., 2015, vol. 22, in press. [0929-8673], IF2013 = 3.715. doi: 10.2174/0929867322666141212120631
  • ZITKO, J.; SERVUSOVÁ, B.; JANOUTOVÁ, A.; PATEROVÁ, P.; MANDÍKOVÁ, J.; GARAJ, V.; VEJSOVÁ, M.; MAREK, J.; DOLEŽAL, M. Synthesis and antimycobacterial evaluation of 5-alkylamino-N-phenylpyrazine-2-carboxamides. Bioorg. Med. Chem., 2015, vol. 23, p. 174–183. [ISSN 0968-0896], IF2013 = 2.951. doi: 10.1016/j.bmc.2014.11.014
  • BHAGYASREE, J. B.; VARGHESE, H. T.; PANICKER, C. Y.; VAN ALSENOY, C.; AL-SAADI, A. A.; DOLEZAL, M.; SAMUEL, J. Spectroscopic (FT-IR, FT-Raman), first order hyperpolarizability, NBO analysis, HOMO and LUMO analysis of 5-tert-Butyl-6-chloro-N-[(4-(trifluoromethyl)phenyl]pyrazine-2-carboxamide. Spectrochim. Acta Part A: Mol. Biomol. Spectr., 2015, vol. 137, p. 193–206. [ISSN 1386-1425]. doi: 10.1016/j.saa, IF2013 = 2.129
  • DOLEŽAL, M.; ZITKO, J. Pyrazine Derivatives: a patent review (June 2012-present). Exp. Opin. Ther. Pat., 2015, vol. 25, p. 33–47. [ISSN 1354-3776]. IF2013 = 3.441. doi: 10.1517/13543776.2014.982533
  • HOLAS, O.; ONDREJČEK, P.; DOLEŽAL, M. Recent progress in discovery of novel Mycobacterium tuberculosis enoyl-ACP reductase inhibitors. J. Enzym. Inhib. Med. Chem., 2015, vol. 30, p. 629-648. [ISSN 1475-6366] doi: 10.3109/14756366.2014.959512, IF2013 = 2.383

2014

  • OPLETALOVÁ, V.; DOLEŽEL, J.;  BUCHTA, V.; VEJSOVÁ, P. PATEROVÁ. Antifungal effects of (5Z)-5-arylmethylidenerhodanines with special view to the members of Mucorales. Folia Pharm. Univ. Carol. 2014, vol. 42, p. 7–13. [ISSN 1210-9495]
  • NEPOVIMOVA, E.; ULIASSI, E.; KORABECNY, J.; PENA-ALTAMIRA, L. E.; SAMEZ, S.; PESARESI, A.; GARCIA, G. E.; BARTOLINI, M.; ANDRISANO, V.; BERGAMINI, C.; FATO, R.; LAMBA, D.; ROBERTI, M.; KUCA, K.; MONTI, B.; BOLOGNESI, M. L. Multitarget Drug Design Strategy: Quinone-Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects. J. Med. Chem. 2014, vol. 57, p. 8576–8589. [ISSN 0022-2623]; doi:10.1021/jm5010804; IF2013 = 5.480
  • MALINAK, D.; DOLEZAL, R.; MAREK, J.; SALAJKOVA, S.; SOUKUP, O.; VEJSOVA, M.; KORABECNY, J.; HONEGR, J.; PENHAKER, M.; MUSILEK, K.; KUCA, K., 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: Synthesis and antimicrobial activity. Bioorg. Med. Chem. Lett., 2014, vol. 24, p. 5238––5241. [ISSN 0960-894X] IF2012 = 2.338, doi: 10.1016/j.bmcl.2014.09.060
  • HAMULAKOVÁ, S.; IMRICH, J.; JANOVEC, L.; KRISTIAN, P.; DANIHEL, I.; HOLAS, O.; POHANKA, M.; BÖHM, S.; KOZURKOVÁ, M.; KUČA K. Tacrine/acridine anticholinesterase inhibitors with piperazine and thiourea linkers. Int. J. Biol. Macromol., 2014, vol. 7, p. 435–439. IF2013 = 2.60. doi: 10.1016/j.ijbiomac.2014.06.064
  • JANĎOUREK, O.; DOLEŽAL, M.; KUNEŠ, J.; KUBÍČEK, V.; PATEROVÁ, P.; PEŠKO, M.; BUCHTA, V.; KRÁĽOVÁ, K.; ZITKO, J. New potentially active pyrazinamide derivatives synthesized under microwave conditions. Molecules, 2014, vol. 19, p. 9318–9338.  [ISSN 1420-3049], IF2013 = 2.095. doi: 10.3390/molecules19079318
  • KORABECNY, J.; DOLEZAL, R.; CABELOVA, P.; HOROVA, A.; HRUBA, E.; RICNY, J.; SEDLACEK, L.; NEPOVIMOVA, E.; SPILOVSKA, K.; ANDRS, M.; MUSILEK, K.; OPLETALOVA, V.; SEPSOVA, V.; RIPOVA, D.; KUCA, K. 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies. Eur. J. Med. Chem., 2014, vol. 82, p. 426–438.  [ISSN 0223-5234], IF2012 = 3.849.  DOI: 10.1016/j.ejmech.2014.05.066
  • KORABECNY, J.; SOUKUP, O.; DOLEZAL, R.; SPILOVSKA, K.; NEPOVIMOVA, E.; ANDRS, M.; NGUYEN, T. D.; JUN, D.; MUSILEK, K.; KUCEROVA-CHLUPACOVA, M.; KUCA, K. From Pyridinium-based to Centrally Active Acetylcholinesterase Reactivators. Mini Rev. Med. Chem., 2014, vol. 14, p. 215–221. [ISSN  1389-5575], IF2014 = 2.903 (Q2) DOI: 10.2174/1389557514666140219103138
  • JANĎOUREK, O.; DOLEŽAL, M.; PATEROVÁ, P.; KUBÍČEK, V.; PEŠKO, M.; KUNEŠ, J.; COFFEY, A.; GUO, J.; KRÁĽOVÁ, K. N-Substituted 5-amino-6-methylpyrazine-2,3-dicarbonitriles: Microwave-assisted synthesis and biological properties. Molecules, 2014, vol. 19, no. 1, p. 651–671. [ISSN 1420-3049], IF2013 = 2.095, doi: 10.3390/molecules19010651
  • SERVUSOVÁ, B.; MANDÍKOVÁ, J.; PATEROVÁ, P.; KUBÍČEK, V.; KUČERA, R.; DOLEŽAL, M.; ZITKO, J. Alkylamino derivatives of pyrazinamide: Synthesis and antimycobacterial evaluation. Bioorg. Med. Chem. Lett., 2014, vol. 24, no. 2, p. 450–453. [ISSN 0960-894X] IF2012 = 2.338, doi: 10.1016/j.bmcl.2013.12.054

2013

  • JOSEPH, T.; VARGHESE, H. T.; PANICKER, C. Y.; VISWANATHAN, K.; DOLEŽAL, M.; MANOJKUMAR, T. K.; VAN ALSENOY, C. Vibrational spectroscopic (FT-IR, FT-Raman) investigations and computational study of N-(4-trifluoromethylphenyl)pyrazine-2-carboxamide. Spectrochim. Acta Part A, 2013, vol. 113, p. 203–214. [ISSN 1386-1425], IF2011 = 2.098
  • SPILOVSKA, K.; KORABECNY, J.; KRAL, J.; HOROVA, A.; MUSILEK, K.; SOUKUP, O.; DRTINOVA, L.; GAZOVA, Z.; SIPOSOVA, K.; KUCA, K. 7-Methoxytacrine-Adamantylamine Heterodimers as Cholinesterase Inhibitors in Alzheimer’s Disease Treatment - Synthesis, Biological Evaluation and Molecular Modeling Studies. Molecules, 2013, vol. 18, no. 2, p. 2397–2418. [ISSN 1420-3049], IF2012 = 2.428. doi:10.3390/molecules18022397
  • KOMLÓOVÁ, M.; HOROVÁ, A.; HRABINOVÁ, M.; JUN, D.; DOLEŽAL, M.; VINŠOVÁ, J.; KUČA, K.; MUSÍLEK, K. Preparation, in vitro evaluation and molecular modelling of pyridinium-quinolinium/isoquinolinium non-symmetrical bisquaternary acetylcholinesterase inhibitors. Bioorg. Med. Chem. Lett., 2013, vol. 23, no. 24, p. 6663–6666. [ISSN 0960-894X] IF2012 = 2.338, doi: http://dx.doi.org/10.1016/j.bmcl.2013.10.043
  • ZITKO, J.; SERVUSOVÁ, B.; PATEROVÁ, P.; MANDÍKOVÁ, J.; KUBÍČEK, V.; KUČERA, R.; HRABCOVÁ, V.; KUNEŠ, J.; SOUKUP, O.; DOLEŽAL, M. Synthesis, Antimycobacterial Activity and in Vitro Cytotoxicity of 5-Chloro-N-phenylpyrazine-2-carboxamides. Molecules, 2013, vol. 18, no. 12, p. 14807–14825. [ISSN 1420-3049], IF2012 = 2.428, doi: 10.3390/molecules181214807
  • Singh, N.; Karpichev, Y.; Gupta, B.; Satnami, M. L.; Marek, J.; Kuča, K.; Ghosh, K. K. Physicochemical Properties and Supernucleophilicity of Oxime Functionalized Surfactants: Hydrolytic Catalysts towards Dephosphorylation of Di- and Tri-phosphate Esters. J. Phys. Chem. B, 2013, vol. 117, no. 14, p. 3806–3817. [ISSN 1520-6106], IF2011= 3.696, DOI: 10.1021/jp310010q
  • Doležal, M.; Vobicková, J.; Servusová, B.; Paterová, P. Aminopyrazinoic acid esters as potential antimycobacterial drugs. Česk. Slov. Farm., 2013, vol. 62, no. 2, p. 84–88. [ISSN 1803-6597]
  • ZITKO, J.; PATEROVÁ, P.; KUBÍČEK, V.; MANDÍKOVÁ, J.; TREJTNAR, F.; KUNEŠ, J.; DOLEŽAL, M. Synthesis and antimycobacterial evaluation of pyrazinamide derivatives with benzylamino substitution. Bioorg. Med. Chem. Lett., 2013, vol. 23, no. 2, p. 476–479. [ISSN: 0960-894X], http://dx.doi.org/10.1016/j.bmcl.2012.11.052, IF2011 = 2.554
  • SERVUSOVÁ, B.; VOBICKOVÁ, J.; PATEROVÁ, P.; KUBÍČEK, V.; KUNEŠ, J.; DOLEŽAL, M.; ZITKO, J. Synthesis and antimycobacterial evaluation of N-substituted 5-chloropyrazine-2-carboxamides. Bioorg. Med. Chem. Lett., 2013, vol. 23, 3589–3591. [ISSN 0960-894X], DOI: 10.1016/j.bmcl.2013.04.021. IF = 2.554
  • OPLETALOVÁ V.; DOLEŽEL, J. Thiosemicarbazones and their antimycobacterial effects. Česk. Slov. Farm. 2013, vol. 62, 78–83. [ISSN 1803-6597]
  • OPLETALOVÁ, V.; KASTNER, P.; KUČEROVÁ-CHLUPÁČOVÁ, M.; PALÁT, K. jr. Study of hydrophobic properties of biologically active open analogues of flavonoids. J. Mol. Graph. Model. 2013, 39, 61–64.  [ISSN 1093-3263], IF2013 2.022 (Q3Q4Q3Q3Q2) http://doi.org/10.1016/j.jmgm.2012.07.009,

2012

  • SERVUSOVA, B.; EIBINOVA, D.; DOLEZAL, M.; KUBICEK, V.; PATEROVA, P.; PESKO, M.; KRALOVA, K. Substituted N-Benzylpyrazine-2-carboxamides: Synthesis and Biological Evaluation. Molecules, 2012, vol. 17, no. 11, p. 13183–13198. [ISSN 1420-3049], IF2011 = 2.386. doi: 10.3390/molecules171113183
  • HOLAS, O.; MUSÍLEK, K.; POHANKA, M.; KUČA, K. The progress in the cholinesterase quantification methods. Exp. Opin. Drug Discov., 2012, vol. 7, no. 12, p. 12071223. [ISSN 1746-0441], DOI:10.1517/17460441.2012.729037, IF2011 = 2.116
  • HERICH, P.; KAMENÍČEK, J.; POHANKA, M.; HOLAS, O.; KOŽÍŠEK, J.; DLHÁŇ, L.; KUČA, K. Planar Ni(II) 1,2-dithiolenes involving tridentate P-donor ligands. J. Coordin. Chem., 2012, vol. 65, no. 1, p. 156164. [ISSN 0095-8972], DOI:10.1080/00958972.2011.644543, IF2011 = 1.547
  • MUSÍLEK, K.; KOMLÓOVÁ, M.; HOLAS, O.; HOROVÁ, A.; ŽĎÁROVÁ-KARASOVÁ, J.; KUČA, K. Myasthenia Gravis – Current Treatment Standards and Emerging Drugs, Chapter 3, p. 2342. In „A Look into Myasthenia Gravis“ by Joseph A. Pruitt (Ed.), 1st ed., Vienna, InTech, January 2012, 106 p. [ISBN: 978-953-307-821-2], DOI: 10.5772/31127. Available from: http://www.intechopen.com/books/a-look-into-myasthenia-gravis/myasthenia-gravis-current-treatment-standards-and-emerging-drugs
  • JANĎOUREK, O.; DOLEŽAL, M.; KLEMENTOVÁ, M.; KRÁĽOVÁ, K.; PEŠKO, M. Microwave assisted synthesis of new pyrazinamide analogues and their biological evaluation. The 16th International Electronic Conference on Synthetic Organic Chemistry, Presented in Section B, Bioorganic, Medicinal and Natural Products Chemistry, November, 1st – 30th, 2012. Published in 2013 by MDPI, Basel, Switzerland [ISBN: 3-906980-26-X], http://www.sciforum.net/presentation/1092
  • DOLEŽAL, M.; ZITKO, J.; JAMPÍLEK, J. Pyrazinecarboxylic acid derivatives with antimycobacterial activity. Chapter 10, p. 233–262. In “Understanding Tuberculosis - New approaches for fighting against drug-resistance“ by Pere-Joan Cardona (ed.), 1st ed., Vienna, InTech, February 2012, 376 p. [ISBN 978-953-307-948-6]
  • Małecki, J. G.; Maroń, A.; Serda, M.; Doležal, M.; Polański, J. Synthesis, characterization and molecular structure of Ru(II) complex with benzoylpyrazine carboxylic acid derivatives. Polyhedron, 2012, vol. 41, no. 1, 104–114. [ISSN 0277-5387], http://dx.doi.org/10.1016/j.poly.2012.04.033, IF2011 = 2.057
  • Joseph, T.; Varghese, H. T.; Panicker, C. Y.; Viswanathan, K.; Sundaraganesan, N.; Subramanian, N.; Doležal, M. Vibrational spectroscopic studies and computational study of 6-chloro-N-(4-trifluoromethylphenyl)-pyrazine-2-carboxamide. Glob. J. Anal. Chem., 2012, vol. 3, no. 18, p. 1–12. [ISSN 0976-5514]
  • ZITKO, J.; JAMPÍLEK, J.; DOBROVOLNÝ, L.; SVOBODOVÁ, M.; KUNEŠ, J.; DOLEŽAL, M. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles. Bioorg. Med. Chem. Lett., 2012, vol. 22, no. 4, p. 1598–1601. DOI: 10.1016/j.bmcl.2011.12.129, [ISSN 0960-894X], IF2011 = 2.554
  • DOLEŽAL, M. Přehled H1 antihistaminik určených nejen pro sezónní pylovou alergii. Prakt. Lékáren., 2012, vol. 8, no. 2, p. 55–61 . [ISSN 1801-2434]
  • DOLEŽAL, M. Perspektivy ve skupině návykových látek. Prakt. Lékáren., 2012, vol. 8, no. 4, p. 170–174. [ISSN 1801-2434]
  • Korábečný, J.; Hrubá, E.; Soukup, O.; Zemek, F.; Musílek, K.; Nepovímová, E.; Špilovská, K.; Opletalová, V.; Kuča, K. Zvažované farmakoterapeutické přístupy léčby Alzheimerovy choroby (Intended pharmacotherapeutical approaches of Alzheimer´s disease therapy). Čes. Slov. Farm., 2012, vol. 61, no. 1, p. 4–10. [ISSN 1210-7816]
  • Holas, O.; Musílek, K.; Horová, A.; Opletalová, V., Kamil, K. SAR Study on reactivators of ethyl-paraoxon inhibited acetylcholinesterase. Lett. Drug Des. & Discov., 2012, vol. 9, no. 6, p. 587–594. [ISSN 1570-1808], DOI:10.2174/157018012800673083, IF2011 = 0.872
  • Opletalová, V.; Doležel, J.; Buchta V.; Vejsová M.; Paterová. P. Antifungal Effects of (5Z)-5-Arylmethylidenerhodanines with a special view to the members of Mucorales. Folia Pharm. Univ. Carol. 2012, vol. 42, in press [ISSN 1210-9495]

2011

  • Opletalová, V.; Doležel, J.; Kráľová, K.; Peško, M.; Kuneš, J.; Jampílek, J. Synthesis and Characterization of (Z)-5-Arylmethylidene-rhodanines with Photosynthesis-Inhibiting Properties. Molecules 2011, vol. 16, no. 6, p. 5207–5227, [ISSN 1420-3049], DOI:10.3390/molecules16065207, IF2011 = 2.386
  • Korábečný, J.; Musílek, K.; Zemek, F.; Horová, A.; Holas, O.; Nepovímová, E.; Opletalová, V.; Hroudová, J.; Fišar, Z.; Jung, Y. S.; Kuča, K. Synthesis and in vitro evaluation of 7-methoxy-N-(pent-4-enyl)-1,2,3,4-tetrahydroacridin-9-amine-new tacrine derivate with cholinergic properties. Bioorg. Med. Chem. Lett., 2011, vol. 21, no. 21, p. 6563–6566, [ISSN 0960-894X], DOI: 10.1016/j.bmcl.2011.08.042, IF2011 = 2.554
  • Doležal, M.; Kráľová, K. Synthesis and evaluation of pyrazine derivatives with herbicidal activity. Chapter 27, p. 581–610. In "Herbicides, Theory and Applications" by Sonia Soloneski and Marcelo L. Larramendy (eds.), 27 chapters, 1st ed., Vienna, InTech, January 2011, 610 p. [ISBN 978-953-307-975-2]
  • TŮMOVÁ, L.; TŮMA, J.; Doležal, M. Pyrazinecarboxamides as potential elicitors of flavonolignan and flavonoid production in Silybum marianum and Ononis arvensis cultures in vitro. Molecules, 2011, vol. 16, no. 11, p. 9142–9152. [ISSN 1420-3049] DOI: 10.3390/molecules16119142, IF2011 = 2.386
  • Musílek, K.; Pavlíková, R.; Komlóová, M.; Holas, O.; Hrabinová, M.; Pohanka, M.; Dohnal, V.; Doležal, M.; Gunn-Moore, F.; Kuča, K. Preparation, in vitro screening and molecular docking of symmetrical bisquaternary cholinesterase inhibitors bearing but-(2E)-en-1,4-diyl connecting linkage. J. Enzym. Inhib. Med. Chem., 2011, vol. 26, no. 2, p. 245–253. [ISSN 1475-6366], IF2011 = 1.617
  • ZITKO, J.; DOLEŽAL, M.; Svobodová, M.; VEJSOVÁ, M.; Kuneš, J.; KUČERA, R.; JÍLEK, P. Synthesis and antimycobacterial properties of N-substituted 6-amino-5-cyanopyrazine-2-carboxamides. Bioorg. Med. Chem., 2011, vol. 19, no. 4, p. 1471–1476. [ISSN 0968-0896], IF2011 = 2.921
  • Musílek, K.; Komlóová, M.; Holas, O.; Hrabinová, M.; Pohanka, M.; Dohnal, V.; Nachon, F.; Doležal, M.; Kuča, K. Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage - Implications for early Myasthenia gravis treatment, Eur. J. Med. Chem., 2011, vol. 46, no. 1, p. 811–818. [ISSN 0223-5234], IF2011 = 3.346
  • Musílek, K.; Komlóová, M.; Holas, O.; Horová, A.; Pohanka, M.; Gunn-Moore, F.; Dohnal, V.; Doležal, M.; Kuča, K. Mono-oxime bisquaternary acetylcholinesterase reactivators with prop-1,3-diyl linkage - Preparation, in vitro screening and molecular docking, Bioorg. Med.Chem., 2011, vol. 19, no. 1, p. 754–762. [ISSN 0968-0896], IF2011 = 2.921
  • Musílek, K.; Doležal, M.; Kuča, K.; Gunn-Moore, F. Design, evaluation and structure-activity relationship studies of the AChE reactivators against organophosphorus pesticides. Med. Res. Rev., 2011, vol. 31, no. 4, p. 548–575. [ISSN 0198-6325], IF2011 = 10.700
  • Doležal, M.; Kešetovič, D.; Zitko, J. Antimycobacterial evaluation of pyrazinecarboxylic acid derivatives. Curr. Pharm. Design, 2011, vol. 17, no. 32, p. 3506–3514. [ISSN 1381-6128], IF2011 = 3.870
  • Musílek, K.; Röder, J.; Komlóová, M.; Holas; O., Hrabinová, M.; Pohanka, M.; Dohnal, V.; Opletalová, V.; Kuča, K.; Jung, J. S. Preparation, in vitro screening  and modelling: Analogues of SAD-128. Bioorg. Med. Chem. Lett., 2011, vol. 21, no. 1, p. 150–154, [ISSN 0960-894X], DOI: 10.1016/j.bmcl.2010.08.051, IF2011 = 2.554

 

© Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského 1203, 500 03 Hradec Králové, Czech Republic
Website information | Powered by Kentico